IVF Blood Test Complete (Women)
Everything in the IVF panel plus full thyroid, preconception nutrients, progesterone and CMV immunity.
17-OH-progesterone is a substance in the adrenal gland that serves as an intermediate product in the making of cortisol; the enzyme 21-hydroxylase converts it into 11-deoxycortisol. In the second half of the menstrual cycle the value is higher, which shows in the separate limits laboratories use for that phase.
When 21-hydroxylase works too little, as in congenital adrenal hyperplasia (CAH), 17-OH-progesterone builds up and part of it is converted into male hormones; in women with the mild form, the Endocrine Society guideline names excess hair growth (hirsutism). Only a blood test shows how much 17-OH-progesterone there is.
17-OH-progesterone is measured in nanomoles per litre: for women aged 18 to 50, Unilabs uses 0.45 to 3 nmol/l in the follicular phase, the first half of the cycle, and 1.0 to 8.5 nmol/l in the luteal phase, the second half after ovulation.
Doctor's Assessment Included
17-OH-progesterone is an intermediate step in the making of cortisol in the adrenal gland, and the standard measurement for establishing congenital adrenal hyperplasia (CAH). The limit differs per laboratory, age, sex and cycle phase.
Reference ranges may vary between laboratories. When you order a test, a BIG-registered doctor assesses your personal results in context. For treatment decisions, discuss your results with your GP.
Check your own value| Laboratory | Group | Reference value (nmol/L) | Relative scale |
|---|---|---|---|
| Star-shl | · Female · 20–29 years · a limit, not a range | < 2.54 nmol/L |
2.54
|
| Star-shl | · Female · 30–39 years · a limit, not a range | < 2.57 nmol/L |
2.57
|
| Star-shl | · Female · 40–49 years · a limit, not a range | < 2.36 nmol/L |
2.36
|
| Star-shl | · Female · 50 years and older · a limit, not a range | < 2.05 nmol/L |
2.05
|
| Unilabs | · Female · 18–50 years · follicular phase | 0.45–3.00 nmol/l |
0.45 3
|
| Unilabs | · Female · 18–50 years · luteal phase | 1.0–8.5 nmol/l |
1 8.5
|
| Unilabs | · Female · 50 years and older · a limit, not a range | < 1.6 nmol/l |
1.6
|
| Certe | · Female · 20–49 years | 0.23–7.56 nmol/L |
0.23 7.56
|
| Certe | · Female · 49–59 years | 0.32–5.24 nmol/L |
0.32 5.24
|
| Certe | · Female · 59–70 years | 0.31–3.75 nmol/L |
0.31 3.75
|
| Certe | · Female · 70–79 years | 0.36–2.36 nmol/L |
0.36 2.36
|
| Diagnostiek voor U | · Female · 20–29 years · a limit, not a range | < 2.54 nmol/L |
2.54
|
| Diagnostiek voor U | · Female · 30–39 years · a limit, not a range | < 2.57 nmol/L |
2.57
|
| Diagnostiek voor U | · Female · 40–49 years · a limit, not a range | < 2.36 nmol/L |
2.36
|
| Diagnostiek voor U | · Female · 50 years and older · a limit, not a range | < 2.05 nmol/L |
2.05
|
| Diagnostiek voor U | · Female · a limit, not a range · follicular phase | < 2.12 nmol/L |
2.12
|
| Diagnostiek voor U | · Female · a limit, not a range · luteal phase | < 8.78 nmol/L |
8.78
|
Source: Star-shl
Source: Unilabs
Source: Certe
Source: Diagnostiek voor U
Each value as the laboratory itself publishes it, retrieved in 2026.
A 17-OH-progesterone measurement gives the amount of 17-hydroxyprogesterone in the serum in nanomoles per litre (nmol/L). In women who menstruate, the Endocrine Society guideline advises measuring early in the follicular phase, and the guideline notes that the result of such a measurement can differ per measuring method.
17-OH-progesterone helps detect the mild, nonclassic form of CAH, which according to the Endocrine Society guideline gives a varying excess of male hormones and sometimes runs without symptoms. According to a genetic analysis the guideline cites, the mild form occurs in about 1 in 200 people in the US population.
In women who menstruate, 17-OH-progesterone is measured early in the follicular phase according to the Endocrine Society guideline, with blood drawn before 8 am. A measurement in the luteal phase comes out higher: Diagnostiek voor U then uses < 8.78 nmol/L, against < 2.12 nmol/L in the follicular phase, which is why the moment in the cycle counts when reading the result.
A low 17-OH-progesterone at Unilabs is, for women aged 18 to 50, a value below 0.45 nmol/l in the follicular phase or below 1.0 nmol/l in the luteal phase; Star-SHL and Diagnostiek voor U name no lower limit for women. A condition that goes with a low value is not in the Endocrine Society guideline.
In women with a high 17-OH-progesterone from the mild form of CAH, the Endocrine Society guideline names excess hair growth (hirsutism), and in adolescents with that mild form irregular periods and acne.
Congenital adrenal hyperplasia from 21-hydroxylase deficiency
According to the Endocrine Society guideline, CAH is caused in about 95% of cases by a fault in the gene for 21-hydroxylase; that enzyme converts 17-OH-progesterone, and with a shortage 17-OH-progesterone builds up.
Mild (nonclassic) CAH
In the mild form, a 17-OH-progesterone measured at a random time can be normal; that is why the guideline advises blood drawn before 8 am.
Other adrenal enzyme shortages
According to the guideline, 17-OH-progesterone can also be raised with a shortage of 11-beta-hydroxylase and, more rarely, of 3-beta-hydroxysteroid dehydrogenase or P450 oxidoreductase.
Pregnancy
According to the guideline, 17-OH-progesterone in the mother is raised in a normal pregnancy.
Second half of the menstrual cycle
In the luteal phase the value is higher: Unilabs then uses 1.0 to 8.5 nmol/l, against 0.45 to 3 nmol/l in the follicular phase, for women aged 18 to 50.
With a raised 17-OH-progesterone, a doctor establishes the cause, and the treatment of women with the mild form of CAH depends on the symptoms, according to the Endocrine Society guideline. For excess hair growth in women with the mild form, the guideline calls a contraceptive pill, with or without an anti-androgen that blocks the action of male hormones, likely the best approach. In women with the mild form who are infertile or have had a miscarriage before, the guideline recommends a glucocorticoid that does not cross the placenta.
Yes, in a normal pregnancy 17-OH-progesterone in the mother is raised, according to the Endocrine Society guideline. For that reason the guideline does not use the value to follow the treatment of CAH during pregnancy.
No, 17-OH-progesterone and progesterone are two different substances: according to the Endocrine Society guideline, the enzyme 21-hydroxylase converts 17-OH-progesterone into 11-deoxycortisol and progesterone into deoxycorticosterone. Star-SHL has a separate determination for each of the two.
The three studies the Endocrine Society guideline cites on the miscarriage chance in the mild form of CAH, an inherited condition in which 17-OH-progesterone builds up in the adrenal gland, disagree. Two retrospective studies found a miscarriage chance of about 25% without a glucocorticoid and 6% with one in women with the mild form; the third study found no difference in miscarriage rate between treated and untreated women.
Add us as a preferred source. Google will then show our articles more often in your search results and in AI overviews. You can turn this off again at any time.
That did not work. Please try again.
These panels measure values from the same category as this marker.
Everything in the IVF panel plus full thyroid, preconception nutrients, progesterone and CMV immunity.
Complete female IVF intake panel: ovarian reserve, thyroid, infectious screening, immunity serology, blood group and CBC.
A hormone test for women measures FSH, LH, estradiol, progesterone and prolactin. Together these five values make a hormonal imbalance visible.
Ovarian reserve panel with AMH, FSH, LH, and Estradiol.
Medical reviewer
Dr. Naimi oversees the medical standards behind our content and assessments.
Medical policyDoctor's Assessment Included
Every result includes a professional assessment from a BIG-registered doctor. For treatment decisions, discuss your results with your GP.
17-OH Progesterone
€81,-
We use cookies to analyze site usage and measure ad effectiveness. Privacy Policy